Discovery of α-Klotho unveiled new insights into calcium and phosphate homeostasis

Proceedings of the Japan Academy Series B: Physical and Biological Sciences

Volumn 85, Issue 3, 2009, Pages 125-141

  Nabeshima, Yo ichi ^a,b  

^a KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

Author keywords

Klotho; FGF23; Mineral homeostasis; Na+,K+ ATPase; PTH; Vitamin D

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); BETA GLUCURONIDASE; CALCIUM; KLOTHO PROTEIN; PARATHYROID HORMONE; PHOSPHATE;

ANIMAL; GENETICS; HOMEOSTASIS; HUMAN; METABOLISM; REVIEW; SECRETION;

ANIMALS; CALCIUM; GLUCURONIDASE; HOMEOSTASIS; HUMANS; PARATHYROID HORMONE; PHOSPHATES; SODIUM-POTASSIUM-EXCHANGING ATPASE;

EID: 67649118226     PISSN: 03862208     EISSN: 13492896     Source Type: Journal    
DOI: 10.2183/pjab.85.125     Document Type: Review

References (99)

1. Kuro-o, M., Matsumura, Y., Aizawa, H., Kawaguchi, H., Suga, T., Utsuki, T. et al. (1997) Mutation of the mouse klotho gene leads to a syndrome resembling ageing. Nature 390, 45-51.
2. Ito, S., Fujimori, T., Furuya, A., Satoh, J., Nabeshima, Y. and Nabeshima, Y. (2005). Impaired negative feedback suppression of bile acid synthesis in mice lacking α-Klotho. J. Clin. Invest. 115, 2202-2208.
3. Takeshita, K., Fujimori, T., Kurotaki, Y., Honjo, H., Tsujikawa, H., Yasui, K. et al. (2004) Sinoatrial node dysfunction and early unexpected death of mice with a defect of klotho gene expression. Circulation 109, 1776-1782.
4. Tsujikawa, H., Kurotaki, Y., Fujimori, T., Fukuda, K. and Nabeshima, Y. (2003) Klotho, a gene related to a syndrome resembling human premature aging, functions in a negative regulatory circuit of vitamin D endocrine system. Mol. Endocrinol. 17, 2393-2403.
5. Urakawa, I., Yamazaki, Y., Shimada, T., Iijima, K., Hasegawa, H., Okawa, K. et al. (2006) Klotho converts canonical FGF receptor into a specific receptor for FGF23. Nature 444, 770-774.
6. 2+ and other ions as extracellular (first) messengers. Physiol. Rev. 71, 371-411.
7. Borle, A.B. (1981) Control, modulation, and regulation of cell calcium. Rev. Physiol. Biochem. Pharmacol. 90, 13-153.
8. Parfitt, A.M. and Kleerekoper, M. (1980) The divalent ion homeostatic system: physiology and metabolism of calcium, phosphorus, magnesium, and bone. In Clinical Disorders of Fluid and Electrolyte Metabolism (3rd ed.) (eds. by Maxwell, M.H. and Kleeman, C.R.). McGraw-Hill, New York, pp. 269-398.
9. 2+ sensing receptor from bovine parathyroid. Nature 366, 575-580.
10. Stewart, A.F. and Broadus, A.E. (1987) Mineral metabolism. In Endocrinology and Metabolism (2nd ed.)(eds. Felig, P., Baxter, J.D., Broadus, A.F. and Frohman, L.A.). New York, McGraw- Hill, pp. 1317-1453.
11. Aurbach, G.D., Marx, S.J. and Spiegel, A.M. (1985) Parathyroid hormone, calcitonin, and the calciferols. In Textbook of Endocrinology (7th ed.) (eds. Wilson, J.D. and Foster, D.W.). PA: Saunders, Philadelphia, pp. 1137-1217.
12. Brown, E.M. (1983) Regulation of the synthesis, secretion and actions of parathyroid hormone. In Contemporary Issues in Nephrology. Divalent Cation Homeostasis (eds. Brenner, B.M. and Stein, J.H.). Churchhill-Livingstone vol. 11, New York, pp. 151-188.
13. Brown, E.M., Chen, C.J., Leboff, M.S., Kifor, O. and El-Hajj, G. (1989) Mechanisms underlying the inverse control of parathyroid hormone secretion by calcium. In Secretion and Its Control (eds. Oxford, G. and Armstrong, C.M.). Rockfeller Univ. Press, New York, pp. 252-268.
14. Austin, L.A. and Heath, III H. (1981) Calcitonin: Physiology and pathophysiology. N. Engl. J. Med. 304, 269-278.
15. Bilezikian, J.P., Marcus, R. and Levine, M.A. (2003) Section II: Physiological aspects of the parathyroid. In The Parathyroids: Basic and Clinical Concepts (2nd ed.) (eds. Bilezikian, J.P., Marcus, R. and Levine, M.A.). Academic Press, New York, pp. 167-291.
16. Brown, E.M. and MacLead, R.J. (2001) Extracellular calcium sensing and extra cellular calcium signaling. Physiol. Rev. 81, 239-297.
17. Blum, J.W., Trescel, U., Born, W., Tobler, P.H., Taylor, C.M., Binswanger, U. et al. (1983) Rapidity of plasma 1,25-dihydroxyvitamin D responses to hypo- and hypercalcemia in steers. Endocrinology 113, 523-526.
18. Brown, E.M., Leombruno, R., Thatcher, J. and Burrowes, M. (1985) The acute secretory response to alterations in the extracellular calcium concentration and dopamine in perfused bovine parathyroid cells. Endocrinology 116, 1123-1132.
19. Wallfelt, C., Lindh, E., Larsson, R., Johansson, H., Rastad, J., Akerstrom, G. et al. (1988) Kinetic evidence for cytoplasmic calcium as an inhibitory messenger in parathyroid hormone release. Biochim. Biophys. Acta 969, 257-262.
20. Raisz, L.G. (1965) Bone resorption in tissue culture: factors influencing the response to parathyroid hormone. J. Clin. Invest. 44, 103-110.
21. Raisz, L.G. and Kream, B.E. (1983) Regulation of bone formation. N. Engl. J. Med. 309, 35-39.
22. Fraser, D.R. and Kodicek, E. (1973) Regulation of 25-hydroxycholecalciferol-hydroxylase activity in kidney by parathyroid hormone. Nature New Biol. 241, 163-166.
23. 3 and 1,25-dihydroxyvitamin D2/D3. Application to hypervitaminosis. D. J. Clin. Invest. 58, 61-70.
24. Hughes, M.R., Brumbaugh, P.F., Haussler, M.R., Wergedal, J.E. and Baylink, J. (1975) Regulation of serum 1,25-dihydroxyvitamin D3 by calcium and phosphate in the rat. Science Wash. DC 190, 578-590.
25. Brumbaugh, P.F., Hughes, M.R. and Haussler, M.R. (1975) Cytoplasmic and nuclear binding components for 1,25-dihydroxyvitamin D3 in chick parathyroid glands. Proc. Natl. Acad. Sci. USA 72, 4871-4875.
26. Marx, S.J., Liberman, U.A. and Eil, C.A. (1983) Calciferols: actions and deficiencyes in actions. Vitam. Horm. 40, 235-308.
27. Cohen, P. (1989) The structure and regulation of protein phosphatases. Annu. Rev. Biochem. 58, 453-508.
28. Hubbard, S.R. and Till, J.H. (2000) Protein tyrosine kinase structure and function. Annu. Rev. Biochem. 69, 373-398.
29. Hunter, T. and Cooper, J. A. (1985) Proteintyrosine kinase. Annu. Rev. Biochem. 54, 897-930.
30. Krebs, E.G. and Beavo, J.A. (1979) Phosphorylation-depphosphorylation of enzymes. Annu. Rev. Biochem. 48, 923-959.
31. Neuman, W. (1980) Bone material and calcification mechanisms. In Fundamental and Clinical Bone Physiology (ed. Urist, M). J.B. Lippincott Co, Philadelphia, pp. 83-107.
32. Knochel, J.P. (1977) The pathophysiology and clinical characteristics of severe hypophosphatemia. Arch. Intern. Med. 137, 203-220.
33. Slatopolsky, E. (2003) New developments in hyperphopsatemia management. J. Am. Soc. Nephrol. 14, 297-299.
34. Werner, A. and Kinne, R.K. (2001) Evolution of the Na-Pi cotransport systems. Am. J. Physiol. Regul. Integr. Comp. Physiol. 280, R301-R312.
35. Beck, L., Karaplis, A.C., Amizuka, N., Hewson, A.S., Ozawa, H. and Tenenhouse, H.S. (1998) Targeted inactivation of Npt2 in mice leads to severe renal phosphate wasting, hypercalciuria, and skeletal abnormalities. Proc. Natl. Acad. Sci. USA 95, 5372-5377.
36. Murer, H., Hernando, N., Forster, I. and Biber, J. (2003) Regulation of Na/Pi transporter in the proximal tubule. Annu. Rev. Physiol. 65, 531-542.
37. Hernando, N., Biber, J., Forster, I. and Murer, H. (2005) Recent advances in renal phosphate transport. Ther. Apher. Dial. 9, 323-327.
38. Berndt, T. and Kumar, R. (2007) Phosphatonins and the regulation of phosphate homeostasis. Annu. Rev. Physiol. 69, 341-359.
39. Condamine, L., Keutmann, H.T., Niall, H.D., Friedlander, G. and Garabedian, M. (1994) Local action of phosphate depletion and insulin-like growth factor 1 on in vitro production of 1,25 dihydroxyvitamin D by cultured mammalian kidney cells. J. Clin. Invest. 94, 1673-1679.
40. Martin, D.R., Ritter, C.S., Slatopolsky, E. and Brown, A.J. (2005) Acute regulation of parathyroid hormone by dietary phosphate. Am. J. Physiol. Endocrinol. Metab. 289, E729-E734.
41. Landsman, A., Lichtstein, D., Bacaner, M. and Ilani, A. (2001) Dietary phosphate-dependent growth is not mediated by changes in plasma phosphate concentration. Br. J. Nutr. 86, 217-223.
42. ADHR Consortium (2000) Autosomal dominant hypophosphataemic rickets is associated with mutations in FGF23. Nat. Genet. 26, 345-348.
43. Rowe, P.S., de Zoysa, P.A., Dong, R., Wang, H.R. and White, K.F. (2000) MEPE, a new gene expressed in bone marrow and causing osteomalacia. Genomics 67, 54-68.
44. Berndt, T., Craig, T.A., Bowe, A.E., Vassiliadis, J. and Reczek, D. (2003) Secreted frizzled-related protein 4 is a potent tumor-derived phosphaturic agent. J. Clin. Invest. 112, 785-794.
45. De Beur, S.M., Finnegan, R.B., Vassiliadis, J., Cook, B. and Barberio, D. (2002) Tumors associated with oncogenic osteomalacia express genes important in bone and mineral metabolism. J. Bone Miner. Res. 17, 1102-1120.
46. Carpenter, T.O., Ellis, B.K., Insogna, K.L., Philbrick, W.M., Sterpka, J. and Shimkets, R. (2005) FGF7: an inhibitor of phosphate transport derived from oncogenic osteomalacia-causing tumors. J. Clin. Endocrinol. Metab. 90, 1012-1020.
47. Hernando, N., Gisler, S.M., Pribanic, S., Deliot, N., Capuano, P., Wagner, C.A. et al. (2005) NaPi-IIa and interacting partners. J. Physiol. 567, 21-26.
48. Henrissat, B. and Davies, G. (1997) Structural and sequence-based classification of glycoside hydrolases. Curr. Opin. Struct. Biol. 7, 637-644.
49. Imura, A., Iwano, A., Kita, N., Thoyama, O., Fujimori, T. and Nabeshima, Y. (2004) Secreted Klotho protein in sera and CSF: implication for post-translational cleavage in release of Klotho protein from cell membrane. FEBS Lett. 565, 143-147.
50. Chang, Q., Hoefs, S., van der Kemp, A.W., Topala, C.N., Bindels, R.J. and Hoenderop, J.G. (2005) The β-glucuronidase klotho hydrolyzes and activates the TRPV5 channel. Science 310, 490-493.
51. 2+ wasting, hyperabsorption, and reduced bone thickness in mice lacking TRPV5. J. Clin. Invest. 112, 1906-1914.
52. Strange, K. (1992) Regulation of solute and water balance and cell volume in the central nervous system. J. Am. Soc. Nephrol. 3, 12-27.
53. Somjen, G.G. (2002) Ion regulation in the brain: implications for pathophysiology. Neuroscientist 8, 254-267.
54. Imura, A., Tsuji, Y., Murata, M., Maeda, R., Kubota, K., Iwano, A. et al. (2007) α-Klotho as a regulator of calcium homeostasis. Science 316, 1615-1618.
55. Shimada, T., Kakitani, M., Yamazaki, Y., Hasegawa, H., Takeuchi, Y., Fujita, T. et al. (2004) Targeted ablation of Fgf23 demonstrates an essential physiological role of FGF23 in phosphate and vitamin D metabolism. J. Clin. Invest. 113, 561-568.
56. Kato, K., Jeanneau, C., Tarp, M.A., Benet-Pagés, A., Lorenz-Depiereux, B., Bennett, E.P. et al. (2006) Polypeptide GalNAc-transferase T3 and familial tumoral calcinosis. Secretion of fibroblast growth factor 23 requires O-glycosylation. J. Biol. Chem. 281, 18370-18377.
57. Ichikawa, S., Imel, E.A., Kreiter, M.L., Yu, X., Mackenzie, D.S., Sorenson, A.H. et al. (2007) A homozygous missense mutation in human KLOTHO causes severe tumoral calcinosis. J. Clin. Invest. 117, 2684-2691.
58. Brownstein, C.A., Adler, F., Nelson-Williams, C., Iijima, J., Li, P., Imura, A. et al. (2008) A translocation causing increased α-Klotho level results in hypophosphatemic rickets and hyperparathyroidism. Proc. Natl. Acad. Sci. 105, 3455-3460.
59. Kilav, R., Silver, J. and Naveh-Many, T. (2001) A conserved cis-acting element in the parathyroid hormone 30-untranslated region is sufficient for regulation of RNA stability by calcium and phosphate. J. Biol. Chem. 276, 8727-8733.
60. Moallem, E., Kilav, R., Silver, J. and Naveh-Many, T. (1998) RNA-protein binding and post-transcriptional regulation of parathyroid hormone gene expression by calcium and phosphate. J. Biol. Chem. 273, 5253-5259.
61. Bell, O., Silver, J. and Naveh-Many, T. (2005) Identification and characterization of cis-acting elements in the human and bovine PTH mRNA 30-untranslated region. J. Bone Miner. Res. 20, 858-866.
62. Silver, J., Kilav, R., Sela-Brown, A. and Naveh-Many, T. (2000) Molecular mechanisms of secondary hyperparathyroidism. Pediatr. Nephrol. 14, 626-628.
63. Ben-Dov, I., Galitzer, H., Lavi-Moshayoff, V., Goetz, R., Kuro-o, M., Mohammadi, M. et al. (2007) The parathyroid is a target organ for FGF23 in rats. J. Clin. Invest. 117(12), 4003-4008.
64. Krajisnik, T., Bjorklund, P., Marsell, R., Ljunggren, O., Akerstrom, G., Jonsson, K.B. et al. (2007) Fibroblast growth factor-23 regulates parathyroid hormone and 1a-hydroxylase expression in cultured bovine parathyroid cells. J. Endocri. 195, 125-131.
65. +-pump. Methods Enzymol. 156, 1-25.
66. +-ATPase. Annu. Rev. Biochem. 71, 511-535.
67. +-ATPase. J. Bioenerg. Biomembr. 24, 249-261.
68. 2+ transport. Biochem. J. 406, 365-382.
69. Blaustein, M.P. and Lederer, W.J. (1999) Sodium/calcium exchange: Its physiologicalimplications. Physiol. Rev. 79, 763-854.
70. Lassiter, W.C., Gottschalk, C.W. and Mylle, M. (1963) Micropuncture study of renal tubular reabsorption of calcium in normal rodents. Am. J. Physiol. 204, 771-775.
71. Rocha, A.S., Magaldi, J.B. and Kokko, J.P. (1977) Calcium and phosphate transport in isolated segments of rabbit Henle's loop. J. Clin. Invest. 59, 975-983.
72. Suki, W.N. (1979) Calcium transport in the nephron. Am. J. Physiol. 237, F1-F6.
73. Quamme, G.A. (1980) Effect of calcitonin on calcium and magnesium transport in rat nephron. Am. J. Physiol. 238, E573-E578.
74. Quamme, G.A. (1982) Effect of hypercalcemia on renal tubular handling of calcium and magnesium. Can. J. Physiol. Pharmacol. 60, 1275-1280.
75. Sutton, R.A., Wong, N.L., Quamme, G.A. and Dirks, J.H. (1983) Renal tubular calcium transport: effects of changes in filtered calcium load. Am. J. Physiol. 245, F515-F520.
76. Kinne-Saffran, E. and Kinne, R. (1974) Localization of a calcium stimulated ATPase in the basallateral plasma membranes of the proximal tubule of rat kidney cortex. J. Membr. Biol. 17, 263-274.
77. 2+ reabsorption in the proximal tubule of the rat kidney. Pfugers. Arch. 364, 223-228.
78. Shareghi, G.R. and Stoner, L.C. (1978) Calcium transport across segments of the rabbit distal nephron in vitro. Am. J. Physiol. 235, F367-F375.
79. Ho, C., Conner, D.A., Pollack, M.R., Ladd, D.J., Kifor, O., Warren, H.B. et al. (1995) A mouse model of human familial hypocalciuric hyper-calcemia and neonatal severe hyperparathyroidism. Nat. Genet. 11, 389-394.
80. Riccardi, D., Park, J., Lee, W.S., Gamba, G., Brown, E.M. and Hebert, S.C. (1995) Cloning and functional expression of a rat kidney extracellular calcium-sensing receptor. Proc. Natl. Acad. Sci. USA 92, 131-135.
81. Wilson, J.D., Foster, D.W., Kronenberg, H.M. and Larsen, P.R. (2003): Hormones and disorders of mineral metabolism. In Williams Textbook of Endocrinology (eds. Bringhurst, F.R., Demay, M.B. and Kronenberg, H.M.). Saunders, Philadelphia, pp. 1303-1371.
82. Tsuruoka, S., Nishiki, K., Ioka, T., Ando, H., Saito, Y. and Kurabayashi, M. et al. (2006) Defect in parathyroid-hormone-induced luminal calcium absorption in connecting tubules of Klotho mice. Nephrol. Dial. Transplant. 21, 2762-2767.
83. Brown, E.M., Watson, E.J., Thatcher, J.G., Koletsky, R., Dawson-Hughes, B.F., Posillico, J.T. et al. (1987) Ouabain and low extracellular potassium inhibit PTH secretion from bovine parathyroid cells by a mechanism that does not involve increases in the cytosolic calcium concentration. Metabolism 36, 36-42.
84. Tohyama, O., Imura, A., Iwano, A., Freund, J.N., Henrissat, B., Fujimori, T. et al. (2004) Klotho is a novel (-glucuronidase capable of hydrolyzing steroid (-glucuronides. J. Biol. Chem. 273, 9777-9784.
85. Cha, S.K., Ortega, B., Kurosu, H., Rosenblatt, K.P., Kuro-o, M. and Huang, C.L. (2008) Removal of sialic acid involving Klotho causes cellsurface retention of TRPV5 channel via binding to galectin-1. Proc. Natl. Acad. Sci. USA 105(28), 9805-9810.
86. Liu, S., Zhou, J., Tang,W., Jiang, X., Rowe, D.W. and Quarles, L.D. (2006). Pathogenic role of Fgf23 in Hyp mice. Am. J. Physiol. Endocrinol. Metab. 291, E38-E49.
87. Kolek, O.I., Hines, E.R., Jones, M.D., LeSueur, L.K., Lipko, M.A., Kiela, P.R. et al. (2005) 1α,25-Dihydroxyvitamin D3 upregulates FGF23 gene expression in bone: the final link in a renalgastrointestinal-skeletal axis that controls phosphate transport. Am. J. Physiol. Gastrointest Liver Physiol. 289, G1036-G1042.
88. Tenenhouse, H. (2005) Regulation of phosphorus homeostasis by the type IIa Na/phosphate cotransporter. Annu. Rev. Nutr. 25, 197-214.
89. Forster, I.C., Hernando, N., Biber, J. and Murer, H. (2006) Proximal tubular handling of phosphate: A molecular perspective. Kidney Int. 70, 1548-1559.
90. Pfister, M.F., Ruf, I., Stange, G., Ziegler, U., Lederer, E., Biber, J. et al. (1998) Parathyroid hormone leads to the lysosomal degradation of the renal type II Na/Pi cotransporter. Proc. Natl. Acad. Sci. USA 95, 1909-1914.
91. Larsson, T., Marsell, R., Schipani, E., Ohlsson, C., Ljunggren, O., Tenenhouse, H.S. et al. (2004) Transgenic mice expressing fibroblast growth factor 23 under the control of the α1(I) collagen promoter exhibit growth retardation, osteomalacia, and disturbed phosphate homeostasis. Endocrinology 145(7), 3087-3094.
92. Bai, X., Miao, D., Li, J., Goltzman, D. and Karaplis, A.C. (2004) Transgenic mice overexpressing human fibroblast growth factor 23(R176Q) delineate a putative role for parathyroid hormone in renal phosphate wasting disorders. Endocrinology 145, 5269-5279.
93. Shimada, T., Hasegawa, H., Yamazaki, Y., Muto, T., Hino, R., Takeuchi, Y. et al. (2004) FGF23 is a potent regulator of the vitamin D metabolism and phosphate homeostasis. J. Bone Miner. Res. 19, 429-435.
94. Segawa, H., Yamanaka, S., Ohno, Y., Onitsuka, A., Shiozawa, K., Aranami, F. et al. (2007) Correlation between hyperphosphatemia and type II Na-Pi cotransporter activity in klotho mice. Am. J. Physiol. Renal Physiol. 292, 769-779.
95. Miyamoto, K., Ito, M., Tatsumi, S., Kuwahara, M. and Segawa, H. (2007) New aspect of renal phosphate reabsorption: The Type IIc sodiumdependent phosphate transporter. Am. J. Nephrology 27, 503-515.
96. Schoeber, J.P.H., Hoenderop, J.G.J. and Bindels, R.J.M. (2007) Concerted action of associated proteins in the regulation of TRPV5 and TRPV6. Biochemical Society Transduction 35, 115-119.
97. Razzaque, M.S. and Lanske, B. (2006) Hypervitaminosis D and premature aging: lessons learned from Fgf23 and Klotho mutant mice. Trends Mol. Med. 12, 298-305.
98. Razzaque, M.S., Sutara, D., Taguchi, T., St-Arnaud, R. and Lanske, B. (2006) Premature aging-like phenotype in fibroblast growth factor 23 null mice is a vitamin D-mediated process. FASEB J. 20, 720-722.
99. Kurosu, H., Yamamoto, M., Clark, A.J.D., Pastor, J.V., Nandi, A., Grunani, P. et al. (2005) Suppression of aging in mice by the hormone Klotho. Science 309, 1829-1833.